Tag: THERMOCOOL

PATIENT ENROLLMENT COMPLETED IN U.S. IDE STUDY OF THERMOCOOL SMARTTOUCH® SF CATHETER FOR TREATMENT OF PERSISTENT ATRIAL FIBRILLATION

IRVINE, CA, — March 13, 2018 — Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has completed patient enrollment in its U.S. Investigational Device Exemption (IDE) study of the THERMOCOOL SMARTTOUCH® SF Catheter. The prospective, […]